Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Most previous investigations focused on the role of homocysteine as direct pathogenetic factor for these adverse vascular events. However, the exact pathophysiological mechanism is still unknown. In this review we discuss the hypothesis that a decreased extracellular concentration of adenosine could contribute to the adverse cardiovascular effects of hyperhomocysteinemia. Fundamental to this hypothesis is that, in vivo, any increase in the plasma concentration of homocysteine reflects an increased intracellular homocysteine concentration, which inevitably will result in a decrease in the adenosine concentration. In this situation, the hydrolase reaction catalysed by S-adenosylhomocysteine hydrolase will reverse and S-adenosylhomocysteine will accumulate at the expense of adenosine. Stimulation of adenosine receptors by adenosine results in various cardio-and vasoprotective actions, like modulation of vascular resistance, presynaptic inhibition of norepinephrine release, ischaemic preconditioning, inhibition of platelet aggregation, modulation of inflammation and regulation of vascular cell proliferation and death. In this respect, a decrease in the adenosine concentration could contribute significantly to the cardiovascular effects of hyperhomocysteinemia.
This article is referred to in the Editorial by A. Deussen concentration of homocysteine is an independent risk (pages 259-261) in this issue.
factor for cardiovascular disease [2] . Up to now, the underlying mechanism causing the cardiovascular complications in hyperhomocysteinemia has been poorly understood. Most investigators in the field 1 . Introduction focused on the role of homocysteine itself and, more recently, of S-adenosylhomocysteine [3] . In this review we Patients with homocysteinuria have severe hyperdiscuss the hypothesis that a decreased extracellular conhomocysteinemia and are particularly prone to occlusive centration of the endogenous nucleoside adenosine could vascular disease at young age [1] . Over the last 2 decades contribute to the pathogenesis of the adverse vascular it became evident that even a mildly elevated plasma effects of hyperhomocysteinemia. Fundamental to this hypothesis is that, in vivo, any increase in the plasma concentration of homocysteine will result in a decrease in the adenosine concentration. Since adenosine is a potent recent case-control study showed that plasma SAH was a cardio-and vasoprotective substance, a decrease in the more sensitive marker of cardiovascular disease than plasma concentration may contribute to the adverse carplasma homocysteine [17] . Wang et al. showed that diovascular sequelae of hyperhomocysteinemia.
incubation of cultured endothelial cells with exogenous homocysteine, only in the presence of adenosine, increases intracellular levels of SAH and inhibits carboxymethylras 2 . Role of homocysteine and S-adenosylhomocysteine ation of p21 , resulting in a decreased cellular proliferation [11] . Since McCully, in 1969, linked elevated plasma homoSo we can conclude that hyperhomocysteinemia is an cysteine concentrations with vascular disease [4] , many independent risk factor for cardiovascular disease and that investigations have been conducted to define the causes of endothelial dysfunction is the most important mediating atherothrombotic complications in hyperhomocysteinemia. mechanism. A direct role for homocysteine itself in the However, up to now, no generally accepted mechanism has pathophysiology of cardiovascular complications, however, been described. Most investigations focused on the role of has not been convincingly shown. In conformity with the homocysteine itself.
hypothesis that there might be other risk factors, associated According to most investigators, endothelial cell injury with high levels of homocysteine, for the development of caused by hyperhomocysteinemia plays a key role in the cardiovascular complications, we now focus on the pospathogenesis of cardiovascular complications (reviews sible role of adenosine in this pathogenesis. [3, 5] ). In vivo, hyperhomocysteinemia rapidly impairs endothelial function [6, 7] . Many in vitro studies have presented evidence of effects of homocysteine on platelets, 3 . Formation and metabolism of homocysteine in man endothelial cells, vascular smooth muscle cells and on coagulation (review [3] ). However, these studies were not Fig. 1 shows the biochemical reactions of homocysteine able to provide conclusive mechanisms for the vascular formation, which are relevant to the current discussion. damage associated with hyperhomocysteinemia. Some During the conversion of methionine to homocysteine, first reports showed that even millimolar concentrations of S-adenosylmethionine is formed with the use of adenosinehomocysteine do not induce platelet aggregation in vitro 5-triphosphate (ATP). In the human body, S-[8]. Further, many publications which did point towards adenosylmethionine is the ultimate methyl donor of many direct vasotoxic or thrombogenic effects of homocysteine vital reactions, like DNA, RNA, protein and phospholipid in vitro are hardly relevant to the clinical situation. Often, methylation. After demethylation, SAH is generated and these studies used very high concentrations reduced homofurther hydrolyzed by the enzyme SAH hydrolase to cysteine (1-10 mM). This is highly unphysiologic because homocysteine and adenosine. So, the net balance shows total homocysteine concentrations are most often between that methionine and ATP are converted to homocysteine, a 10 and 30 mmol / l in plasma of patients with mild methyl group and adenosine. This pathway may signifihyperhomocysteinemia. Moreover, in blood almost all cantly contribute to the production of adenosine in man homocysteine is present in its oxidized disulfide form and ( Fig. 1 , left panel). Metabolic balance studies in normal only a very small amount of 1%, or even less, of the total adults have shown that the generation of adenosine from pool of blood homocysteine, is present in its reduced form SAH is about 20 mmol per day [18] . Several in vitro [9] . This means that 10 mM of homocysteine in vitro is studies have quantified the rate of adenosine production about 50 000 times the plasma level normally occurring in from this transmethylation pathway in rat and guinea pig patients with mild hyperhomocysteinemia [10] .
heart [19] [20] [21] [22] [23] . It was shown that during normoxia, SAH In summary, no coherent, generally accepted view has hydrolysis significantly contributes to the intracellular emerged to explain the pathophysiology of atherosclerotic adenosine production (up to one third of total). During and thrombotic complications in hyperhomocysteinemia.
hypoxia, however, adenosine is predominantly derived One potential explanation for these inconsistent results is from enhanced hydrolysis of adenosine-monophosphate that not hyperhomocysteinemia itself causes vascular (AMP). It should be realized that the contribution of the damage, but that high levels of homocysteine are merely a transmethylation pathway to adenosine production can marker for another risk factor. Recently, several studies differ significantly between various organ systems [15] . have provided evidence that not homocysteine, but Sadenosylhomocysteine (SAH), may play an important role in the vascular complications of hyperhomocysteinemia 4 . Adenosine in hyperhomocysteinemia [11] [12] [13] [14] . When concentrations of homocysteine are high, the hydrolase reaction catalysed by the SAH hydrolase Of all enzymes in the aforementioned metabolic pathreverses and SAH is formed from homocysteine and way, only SAH hydrolase is able to function in both adenosine. SAH in turn is a potent inhibitor of transdirections [3, 15] . In fact, the equilibrium of the reaction methylation reactions in the cell [15, 16] . Interestingly, a catalyzed by SAH hydrolase favours SAH formation. Nonetheless, the reaction is driven in the opposite direction result in a lower plasma adenosine level, provided that because the products homocysteine and adenosine are both other routes of adenosine metabolism remain constant. rapidly removed in the normal in vivo situation, causing Indeed, several studies showed that the administration of the enzyme to function in its cleavage direction. However, homocysteine or homocysteine thiolactone decreases in case of increased levels of homocysteine, SAH will adenosine release [26, 27] . In the study by Sciotti and van accumulate at the expense of adenosine (Fig. 1, right Wylen, microdialysis probes were used to measure the panel). Under these circumstances, intracellular adenosine adenosine concentration in cerebral interstitial fluid (ISF) formation is hampered, increasing the transmembrane in a rat model under different conditions [26] . This study adenosine concentration gradient that exists under normoxshowed that infusion of homocysteine thiolactone in the 25 23 ic conditions [24] , and, consequently, the extracellular probe, in concentrations of 10 -10 M, decreases basal adenosine concentration is decreased.
ISF adenosine concentration and cerebral blood flow. It is essential to realise that under baseline normoxic Moreover, it showed that homocysteine thiolactone atconditions, adenosine is produced continuously in several tenuates the increase in dialysate adenosine during iscell types, originating from two different pathways. The chaemia. A comparable experiment was conducted in first is the hydrolysis of SAH by SAH hydrolase. A second perfused isolated guinea-pig hearts, in which under hypimportant pathway in adenosine formation is the intra-and oxic conditions, homocysteine thiolactone was shown to extracellular hydrolysis of AMP by 59-nucleotidase. Under decrease the adenosine concentration in the perfusate by hypoxic conditions, the hydrolysis of AMP greatly inmore than 50%, while the tissue content of SAH increased creases and predominates the other pathway. Under norsignificantly [27] . However, not all studies on this subject moxic conditions, adenosine is quickly taken up by showed similar unequivocal results. Deussen et al. found neighbouring cells via nucleoside transporters and is attenuation of adenosine release with homocysteine during degraded to inosine by adenosine deaminase or rephoshypoxia, but were not able to show an effect of homophorylated by adenosine kinase [25] . As such, the plasma cysteine on coronary flow during hypoxia [28] . Also, in the concentration of adenosine is determined by the sum of dog heart, homocysteine thiolactone was shown not to these processes, and a fall in the formation of adenosine influence reactive hyperaemia, which is believed to be originating from the hydrolysis of SAH should inevitably mediated by adenosine [29] . This discrepancy could be explained by the multitude of mechanisms, other than endothelial cells and by suppressing the expression of adenosine, which contribute to reactive hyperaemia [30] .
P-selectin on platelets [42, 43] . These effects may well Although these studies convincingly illustrated the mechacontribute to the well-known antithrombogenicity of an nism we described of the homocysteine-induced decrease intact endothelial lining. in adenosine concentration, it has to be emphasized that in Fourthly, adenosine, at concentrations similar to those these experiments, supraphysiological homocysteine conobserved in vivo, is an important anti-inflammatory agent centrations were used and that they do not mimic the [44, 45] . Adenosine receptor stimulation inhibits the activasituation of hyperhomocysteinemia in man. Moreover, tion of neutrophils and protects vascular endothelium from these studies showed that, although the contribution of damage by neutrophils [46] . Moreover, adenosine inhibits SAH hydrolysis to basal adenosine formation is limited, TNF-a production in macrophages and monocytes [47], under hypoxic conditions (when adenosine production is suppresses arachidonic acid release and leukotriene biomostly from AMP hydrolysis) and with high homocysteine synthesis in human neutrophils [48] , and is shown to act as levels, this pathway can contribute significantly to intracelan endogenous activator of cellular antioxidant enzyme lular adenosine trapping. Very recently, Chen et al. found systems [49] . that acute as well as chronic hyperhomocysteinemia in rat Fifthly, adenosine has been shown to play an important decreases plasma and renal interstitial adenosine concenrole in the regulation of vascular cell proliferation and tration through the inhibition of SAH hydrolase [31] . This death, which plays a key role in the vascular remodelling study more closely resembled the human situation of process that leads to vaso-occlusive diseases [50] . Smooth hyperhomocysteinemia, in that a plasma homocysteine muscle cell derived adenosine inhibits the proliferation and concentration of approximately 15 mM was induced.
collagen synthesis of these muscle cells in an autocrine manner via adenosine A receptor stimulation [51-53].
2B
Moreover, a selective A receptor agonist was shown to 2
. Effects of endogenous adenosine
reduce neointimal thickening in an animal model [54] . In contrast to the growth-inhibitory effect on vascular smooth Extracellular adenosine may exert several physiological muscle cells, adenosine A receptor stimulation induces 2B effects by stimulation of specific adenosine receptors. mitogenic effects on endothelial cell [55] . Besides inhibThese adenosine receptors can be subdivided into A , A , iting the growth of vascular smooth muscle cells, adeno-
A and A receptors [32] . By stimulation of these sine has been shown to induce apoptosis of human 2B 3 receptors, adenosine exerts a multitude of cardio-and vascular smooth muscle cells via A receptor stimulation 2B vasoprotective effects by interfering with numerous mech- [56] . In this way, adenosine could restrict intimal hyanisms that contribute to the pathogenesis of atheroscleroperplasia in the early phase of atherosclerosis, but on the sis and thrombosis.
other hand, could also play a role in the formation of the Firstly, adenosine exhibits direct and indirect effects on necrotic core in advanced atherosclerosis. Regarding the vascular tone. Directly, predominantly via activation of A effects of adenosine on vascular cell proliferation and 2 receptors, adenosine induces vasodilation [25] . Indirectly, death, the net effect would be to facilitate the recovery of adenosine blocks the synthesis of potent vasoconstrictor blood vessels from injury by the inhibition of inappropriate factors such as angiotensin II and norepinephrine by migration and proliferation of vascular smooth muscle inhibiting renin release [33] . At the level of the vascular cells into the intima layer and promoting re-endothelializasmooth muscle cell, adenosine has been reported to inhibit tion via its mitogenic effects on endothelial cells [55] . the release of the neurotransmitter norepinephrine and to All these effects make adenosine a powerful endogenous reduce the postsynaptic vasoconstrictor response to aprotector against arteriosclerotic and vaso-occlusive disadrenoceptor-stimulation in man [34, 35] .
orders and are thought to contribute to the well-docuSecondly, several direct cardioprotective effects of mented cardioprotective properties of adenosine receptor adenosine are known. It exerts negative inotropic, chronotstimulation [57, 58] . In this respect, a decreased plasma and ropic and dromotropic cardiac effects [36] . Adenosine has interstitial adenosine concentration in hyperalso been reported to play a key role in ischaemic homocysteinemia could significantly contribute to the preconditioning of the heart. This phenomenon concerns cardiovascular complications of this disorder. The recent the observation that short periods of ischaemia render the study by Chen et al. strongly supports this view by indeed myocardium resistant to a subsequent more serious isshowing a decreased plasma and renal interstitial adenochaemic event [37] . A number of studies have shown that sine concentration in hyperhomocysteinemia in vivo [31] . this endogenous cardioprotective mechanism can be re-A significant role for adenosine in vascular complicaduced by adenosine receptor antagonism [38] , and potentions is not unique. Recently this was also established for tiated by dipyridamole, an adenosine uptake inhibitor [39] .
hypertension in the spontaneously hypertensive rat (SHR). Thirdly, adenosine potently inhibits the aggregation of Extracellular adenosine levels in cultured vascular smooth platelets [40, 41] . Moreover, adenosine exerts anticoagulant muscle cells were significantly lower in SHRs than in activity by downregulation of tissue factor expression on Wistar Kyoto rats (WKY) and this difference mediated the hyperhomocysteinemia [60] . Moreover, in future experi- adenosine in the human situation.
